Development of the Specific Immunotherapy for Myocarditis, Dilated Cardiomyopathy(Chronic Myocarditis), and Takayasu Arteritis.

心肌炎、扩张型心肌病(慢性心肌炎)、大动脉炎的特异性免疫疗法的开发。

基本信息

  • 批准号:
    11557048
  • 负责人:
  • 金额:
    $ 8.64万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2000
  • 项目状态:
    已结题

项目摘要

1. Analysis of T-cell receptor(TCR)clonality of the heart infiltrating cells in myocarditis and dilated cardiomyopathy(DCM) : SSCP showed that TCR Vβ clonality was oligoclonal and about 40% of the total clones were identical among different three parts in the same heart and that about 40% of such clones also expanded in the peripheral blood. This indicates a possibility of identification of the antigen recognized by pathogenic T-cell clones playing a primary role in the development of the disease by collecting them from peripheral blood. 2. Analysis of costimulatory molecules playing an important role in the T-cell-mediated myocardial damage in acute and chronic myocarditis : (A)We analyzed TNF receptor/ligand superfamily costimulatory molecules in murine acute myocarditis, and found that CD30L, 4-1BBL, Fas were induced on cardiac myocytes and in vivo anti-4-1BBL or -FasL mAb administration significantly reduced the myocardial damage, indicating the critical role of 4-1BB/4-1BBL and Fa … More s/FasL pathways involved. (B)We found the induction of CD27L, CD30L, OX40L, and 4-1BBL on cardiac myocytes and expression of their counterpart by the infiltrating cells in patients with acute myocarditis and DCM, suggesting the role of these costimulatory molecules in the pathogenesis is of human myocarditis as well. 3. Analysis of TCR clonality of the arterial infiltrating cells in Takayasu Arteritis : (A)SSCP showed that TCR Vβ clonality was oligoclonal and most of the clones were identical between different two parts in the same arterial tissue, suggesting that limited clones infiltrated and recognized a certain antigen and caused vascular damage. (B)TCR γδ repertoire of the infiltrating cells was oligoclonal as was TCR αβ. 4. Analysis of costimulatory molecules in Takayasu Arteritis : It is strongly suggested that among TNF receptor/ligand superfamily costimulatory molecules, especially 4-1BB/4-1BBL and Fas/FasL pathways play an important role in the vascular damage involved in Takayasu Arteritis. Less
1. 心肌炎和扩张型心肌病(DCM)心脏浸润细胞的t细胞受体(TCR)克隆分析:SSCP显示TCR Vβ克隆为寡克隆,在同一心脏的不同三个部位中约有40%的克隆是相同的,约40%的克隆在外周血中也有扩增。这表明有可能通过从外周血中收集病原性t细胞克隆识别的抗原,这些抗原在疾病的发展中起主要作用。2. 急慢性心肌炎中t细胞介导心肌损伤的共刺激分子分析(A)我们分析了小鼠急性心肌炎中TNF受体/配体超家族共刺激分子,发现CD30L、4-1BBL、Fas可诱导心肌细胞,体内抗4-1BBL或-FasL单抗可显著减轻心肌损伤,表明4-1BB/4-1BBL和Fa…更多s/FasL通路参与其中。(B)在急性心肌炎和DCM患者中,我们发现CD27L、CD30L、OX40L和4-1BBL在心肌细胞上的诱导作用,并通过浸润细胞表达相应的CD27L、CD30L、OX40L和4-1BBL,提示这些共刺激分子在人类心肌炎的发病机制中也有作用。3. 高松动脉炎动脉浸润细胞的TCR克隆分析:(A)SSCP显示TCR Vβ克隆为寡克隆,且同一动脉组织中不同部位的TCR Vβ克隆大部分相同,提示有限克隆浸润并识别某种抗原,造成血管损伤。(B)浸润细胞的TCR γδ库为寡克隆,TCR αβ库为寡克隆。4. 高松动脉炎共刺激分子分析:强烈提示TNF受体/配体超家族共刺激分子,特别是4-1BB/4-1BBL和Fas/FasL通路在高松动脉炎血管损伤中起重要作用。少

项目成果

期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Seko Y: "Takayasu arteritis : Insight into immunopathology"Jpn Heart J. 41. 15-26 (2000)
Seko Y:“高安动脉炎:免疫病理学的见解”Jpn Heart J. 41. 15-26 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seko Y, Takahashi N, Yagita H, Okumura K, Azuma M, Yazaki Y: "Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on the survival of mice with chronic ongoing myocarditis caused by coxsackievirus B3."J Pathol. 188. 107-112 (1999)
Seko Y、Takahashi N、Yagita H、Okumura K、Azuma M、Yazaki Y:“体内施用抗 B7-1/B7-2 单克隆抗体对柯萨奇病毒 B3 引起的慢性持续性心肌炎小鼠存活的影响。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seko Y: "Takayasu's arteritis : pathogenesis, in Inflammatory Diseases of Blood Vessels"Marvel Dekker,Inc (in press).
Seko Y:“高安动脉炎:血管炎症性疾病中的发病机制”Marvel Dekker, Inc(印刷中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seko Y, et al.: "Expression of tumor necrosis factor(TNF) ・・・・・"J Pathol. 188. 423-430 (1999)
Seko Y 等人:“肿瘤坏死因子 (TNF) 的表达……”J Pathol 188. 423-430 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Seko Y, Takahashi N, Oshima H, Shimozato O, Akiba H, Kobata T et al: "Expression of tumor nccrosis factor(TNF)receptor ligand superfamily costimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by cox
Seko Y、Takahashi N、Oshima H、Shimozato O、Akiba H、Kobata T 等人:“肿瘤坏死因子 (TNF) 受体配体超家族共刺激分子 CD40、CD30L、CD27L 和 OX40L 在引起慢性持续性心肌炎的小鼠心脏中的表达
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SEKO Yoshinori其他文献

SEKO Yoshinori的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SEKO Yoshinori', 18)}}的其他基金

Identification of the Receptor for ORAIP That Mediates Cardiac Response to Oxidative Stresses and Development of Treatment
介导心脏对氧化应激反应的 ORAIP 受体的鉴定和治疗方法的开发
  • 批准号:
    15390240
  • 财政年份:
    2003
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of the ligands for Cardiac Orphan G protein -Coupled Receptors and Development of T herapy Modulating Cardiac Function
心脏孤儿 G 蛋白偶联受体配体的鉴定及心脏功能调节疗法的开发
  • 批准号:
    13470140
  • 财政年份:
    2001
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Purification and Identification of the Bioactive Subs tance That Mediates Cardiac Response to the Ischemia Reperfusion Stresses and Development of Treatment
介导心脏对缺血再灌注应激反应的生物活性物质的纯化和鉴定以及治疗方法的开发
  • 批准号:
    11470158
  • 财政年份:
    1999
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Elucidation of the Molecular Mechanism of Cardiac Response to the Ischemia Reperfusion Stresses and Establishment of Treatment Based on the Molecular Mechanism
阐明心脏对缺血再灌注应激反应的分子机制并建立基于分子机制的治疗方法
  • 批准号:
    09470162
  • 财政年份:
    1997
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of Molecular Biologic Diagnostic and Therapeutic Method of Asymptomatic Myocardial Ischemia and Unstable Angina
无症状心肌缺血及不稳定型心绞痛分子生物学诊断及治疗方法的进展
  • 批准号:
    07557231
  • 财政年份:
    1995
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)

相似海外基金

Decoding Dilated Cardiomyopathy in vitro: Linking Genetic Mutations to Phenotypic Dysfunction
体外解码扩张型心肌病:将基因突变与表型功能障碍联系起来
  • 批准号:
    495567
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Miscellaneous Programs
Enabling advances in diagnosis, patient stratification and treatment for dilated cardiomyopathy patients and families (DCM Next)
促进扩张型心肌病患者和家庭的诊断、患者分层和治疗取得进展 (DCM Next)
  • 批准号:
    10085929
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    EU-Funded
Evaluating sex specific differences in dilated cardiomyopathy
评估扩张型心肌病的性别特异性差异
  • 批准号:
    MR/W023830/1
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Fellowship
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy
使用 miRNA 确定扩张型心肌病的新治疗途径
  • 批准号:
    10740082
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Dysregulated mechanosignaling in dilated cardiomyopathy caused by defective Filamin C
Filamin C 缺陷引起的扩张型心肌病的机械信号失调
  • 批准号:
    10877387
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Development of strategies to enhance titin (TTN) expression and treat dilated cardiomyopathy caused by TTN haploinsufficiency
开发增强肌联蛋白 (TTN) 表达并治疗 TTN 单倍体不足引起的扩张型心肌病的策略
  • 批准号:
    10662742
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Elucidation of pathogenesis mechanisms and exploration of therapeutic strategies using mouse models of dilated cardiomyopathy
扩张型心肌病小鼠模型阐明发病机制并探索治疗策略
  • 批准号:
    23K18221
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Discovery and Characterization of Rare Variant Effects in Dilated Cardiomyopathy via Large-Scale Biobank Analysis
通过大规模生物库分析发现和表征扩张型心肌病的罕见变异效应
  • 批准号:
    10682290
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
Elucidation of Molecular Basis for Myocardial Fibrosis in Dilated Cardiomyopathy
扩张型心肌病心肌纤维化的分子基础阐明
  • 批准号:
    23K15174
  • 财政年份:
    2023
  • 资助金额:
    $ 8.64万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了